Relay Therapeutics (RLAY) Shares Issued (2019 - 2024)

Relay Therapeutics (RLAY) has 6 years of Shares Issued data on file, last reported at $218.2 million in Q3 2024.

• Shares Issued for Q3 2024 came in at $218.2 million, up 2221.28% year-over-year; the trailing twelve-month figure through Sep 2024 was $246.0 million (down 16.74% YoY), and the FY2024 annual result was $17.9 million, down 40.92% from the prior year.
• Shares Issued climbed to $218.2 million in Q3 2024 per RLAY's latest filing, from $17.9 million in the prior quarter.
• Over five years, Shares Issued peaked at $427.1 million in Q3 2020 and troughed at -$426.6 million in Q4 2020.
• A 5-year average of $35.7 million and a median of $902000.0 in 2021 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 355801.67% in 2020 and fell as far as 96831.07% in 2020.
• A 5-year view of Shares Issued shows it stood at -$426.6 million in 2020, then jumped by 99.31% to -$2.9 million in 2021, then jumped by 118.69% to $549000.0 in 2022, then jumped by 1612.2% to $9.4 million in 2023, then surged by 2221.28% to $218.2 million in 2024.
• Business Quant data shows RLAY's Shares Issued at $218.2 million in Q3 2024, $17.9 million in Q1 2024, and $9.4 million in Q3 2023.